CD34 and diabetic kidney disease: Similarly, our results suggest that the administration of cultured CD34+ cells may improve kidney tissue by upregulating angiogenesis and anti-inflammation responses, as evidenced by preserved PTC integrity and reduced glomerular macrophage infiltration in the rat model of STZ-induced diabetic nephropathy.